Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Seoul National University Bundang Hospital
Azienda Ospedaliero-Universitaria di Parma
Mayo Clinic
Universitair Ziekenhuis Brussel
University of Pittsburgh
Bicara Therapeutics
The Center for Clinical and Cosmetic Research